In this review, we focus on prenatal opioid exposure (POE) given the significant concern for
the mental health outcomes of children with parents affected by opioid use disorder (OUD) in …

The increasing use of opioids in pregnant women has led to an alarming rise in the number
of cases of neonates with drug-induced withdrawal symptoms known as neonatal opioid …

Maternal opioid use poses a significant health concern not just to the expectant mother but
also to the fetus. Notably, increasing numbers of children born suffering from neonatal opioid …

Background: The opioid overdose and opioid use disorder epidemics are concomitant with
increased metabolic and CVD risk. Although opioid use disorder causes adverse pregnancy …

Methods This study is a qualitative study of parenting women from one urban, academic
OUD treatment program and pediatric primary care clinicians from a nearby affiliated …

Introduction Infants exposed to opioids in utero are at high risk of exhibiting Neonatal Opioid
Withdrawal Syndrome (NOWS), a combination of somatic withdrawal symptoms including …

Neonatal opioid withdrawal syndrome (NOWS) is a growing public health concern. The
complexity of in utero opioid exposure in clinical studies makes it difficult to investigate …

Introduction Rates of neonatal opioid withdrawal syndrome (NOWS) have paralleled the rise
of opioid use during pregnancy. While short-term phenotypic symptoms of NOWS are well …

Abstract Objective Neonatal Opioid Withdrawal Syndrome (NOWS) has been associated
with the development of necrotizing enterocolitis (NEC) in term and late-preterm neonates …

Objective The difference in infant health outcomes by maternal opioid use disorder (OUD)
status is understudied. We measured the association between maternal OUD during …